| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8433088 | Cancer Epidemiology | 2016 | 6 Pages |
Abstract
These findings provide the first evidence that DNA methylation within the promoter region of the ERCC2 gene may be associated with survival in pediatric medulloblastoma. If confirmed in future studies, this information may lead to improved risk stratification or promote the development of novel, targeted therapeutics.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emilyn Banfield, Austin L. Brown, Erin C. Peckham, Surya P. Rednam, Jeffrey Murray, M. Fatih Okcu, Laura E. Mitchell, Murali M. Chintagumpala, Ching C. Lau, Michael E. Scheurer, Philip J. Lupo,